6-phosphogluconate dehydrogenase, decarboxylating

BE0003559ProteinHumansPGD

Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. It is acted on by 12 drugs in DrugBank.

Gene name
PGD
UniProtKB entry
P52209Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
483 residues · 53,140 Da
Also known as
1.1.1.44 · PGDH

Resolves to

Protein
UniProtP52209UniProt name6PGD_HUMAN
Gene
HGNCHGNC:8891NCBI Gene5226GenBank984325GeneCardsPGD
Pharmacology
KEGGhsa:5226
Structure
PDB2JKVPDB4GWGPDB4GWK
Drugs

What you can answer from here — as of September 07, 2019

12DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
10GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
32+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on 6-phosphogluconate dehydrogenase, decarboxylating, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In